AIMS: We examine the co-occurrence of abuse/dependence across different illicit drugs and test associations between these classes and major psychiatric disorders. METHOD: Latent class analyses were used to characterize polysubstance abuse/dependence (AB/D) in 43 093 individuals who participated in the National Epidemiological Survey on Alcohol and Related Conditions. Multinomial logistic regression was performed to examine the association between the classes of life-time illicit drug AB/D and gender, age and race, as well as life-time Diagnostic and Statistical Manual version IV (DSM-IV) alcohol abuse/dependence, nicotine dependence, major depressive disorder, generalized anxiety disorder, panic disorder, social phobia and antisocial personality disorder. RESULTS: Five latent classes were identified: no AB/D (class 1: 92.5%), cannabis AB/D only (class 2: 5.8%), stimulants + hallucinogen AB/D (class 3: 0.6%), prescription drug AB/D (class 4: 0.6%) and polysubstance AB/D (class 5: 0.5%). Major depressive disorder and nicotine dependence were associated most strongly with class 5. Anxiety disorders were associated strongly with the prescription drug AB/D class while alcohol AB/D and ASPD were associated with classes 2, 3, 4 and 5 when compared to the reference class (class 1). CONCLUSIONS: Significant heterogeneity exists in this US population for polysubstance AB/D patterns with evidence for a subgroup with high rates of sedative, tranquilizer and opiate AB/D and a history of anxiety disorders, a stimulant/hallucinogens group, a high-risk group with elevated rates of all psychiatric disorders and a milder cannabis AB/D only group. Replication of such classes across other samples has significant implications, such as characterizing risk groups that may be etiologically diverse.
AIMS: We examine the co-occurrence of abuse/dependence across different illicit drugs and test associations between these classes and major psychiatric disorders. METHOD: Latent class analyses were used to characterize polysubstance abuse/dependence (AB/D) in 43 093 individuals who participated in the National Epidemiological Survey on Alcohol and Related Conditions. Multinomial logistic regression was performed to examine the association between the classes of life-time illicit drug AB/D and gender, age and race, as well as life-time Diagnostic and Statistical Manual version IV (DSM-IV) alcohol abuse/dependence, nicotine dependence, major depressive disorder, generalized anxiety disorder, panic disorder, social phobia and antisocial personality disorder. RESULTS: Five latent classes were identified: no AB/D (class 1: 92.5%), cannabis AB/D only (class 2: 5.8%), stimulants + hallucinogen AB/D (class 3: 0.6%), prescription drug AB/D (class 4: 0.6%) and polysubstance AB/D (class 5: 0.5%). Major depressive disorder and nicotine dependence were associated most strongly with class 5. Anxiety disorders were associated strongly with the prescription drug AB/D class while alcohol AB/D and ASPD were associated with classes 2, 3, 4 and 5 when compared to the reference class (class 1). CONCLUSIONS: Significant heterogeneity exists in this US population for polysubstance AB/D patterns with evidence for a subgroup with high rates of sedative, tranquilizer and opiate AB/D and a history of anxiety disorders, a stimulant/hallucinogens group, a high-risk group with elevated rates of all psychiatric disorders and a milder cannabis AB/D only group. Replication of such classes across other samples has significant implications, such as characterizing risk groups that may be etiologically diverse.
Authors: Frederic C Blow; Maureen A Walton; Kristen L Barry; Regan L Murray; Rebecca M Cunningham; Lynn S Massey; Stephen T Chermack; Brenda M Booth Journal: Addict Behav Date: 2010-12-29 Impact factor: 3.913
Authors: Philip A Chan; Jennifer Rose; Justine Maher; Stacey Benben; Kristen Pfeiffer; Alexi Almonte; Joanna Poceta; Catherine E Oldenburg; Sharon Parker; Brandon Dl Marshall; Mickey Lally; Kenneth Mayer; Leandro Mena; Rupa Patel; Amy S Nunn Journal: AIDS Patient Care STDS Date: 2015-09-21 Impact factor: 5.078
Authors: Paul T Harrell; Syeda Mahrukh Hussnain Naqvi; Andrew D Plunk; Ming Ji; Silvia S Martins Journal: Am J Drug Alcohol Abuse Date: 2016-09-26 Impact factor: 3.829
Authors: Carlos Blanco; María García-Anaya; Melanie Wall; José Carlos Pérez de Los Cobos; Ewelina Swierad; Shuai Wang; Nancy M Petry Journal: Drug Alcohol Depend Date: 2015-02-25 Impact factor: 4.492
Authors: Theodore Krmpotich; Susan Mikulich-Gilbertson; Joseph Sakai; Laetitia Thompson; Marie T Banich; Jody Tanabe Journal: J Addict Med Date: 2015 Jul-Aug Impact factor: 3.702